Stimulation of Suicidal Erythrocyte Death by the Antimalarial Drug Mefloquine

Cellular Physiology and Biochemistry

Volumn 36, Issue 4, 2015, Pages 1395-1405

  Bissinger, Rosi ^a   Barking, Susanne ^a   Alzoubi, Kousi ^a   Liu, Guilai ^a   Liu, Guoxing ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Calcium; Cell volume; Eryptosis; Malaria; Oxidative stress; Phosphatidylserine; ROS

Indexed keywords

CALCIUM ION; CERAMIDE; DICHLORODIHYDROFLUORESCEIN DIACETATE; LIPOCORTIN 5; MEFLOQUINE; REACTIVE OXYGEN METABOLITE; ANTIMALARIAL AGENT; CALCIUM;

ANTIGEN BINDING; ARTICLE; CELL DEATH; CELL STIMULATION; CELL VOLUME; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ERYPTOSIS; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; ERYTHROCYTE SHAPE; ERYTHROCYTE VOLUME; EXTRACELLULAR CALCIUM; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; UPREGULATION; APOPTOSIS; CELL SIZE; CYTOLOGY; DRUG EFFECTS; MALARIA; METABOLISM;

ANTIMALARIALS; APOPTOSIS; CALCIUM; CELL SIZE; CERAMIDES; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HUMANS; MALARIA; MEFLOQUINE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84936935105     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430305     Document Type: Article

References (74)

1. Bukirwa H, Orton L: Artesunate plus mefloquine versus mefloquine for treating uncomplicated malaria. Cochrane Database Syst Rev 2005;10. 1002/14651858. CD004531. pub2CD004531.
2. Cayley WE, Jr.: Mefloquine for preventing malaria in nonimmune adult travelers. Am Fam Physician 2004;69:521-522.
3. Croft AM, Garner P: Mefloquine for preventing malaria in non-immune adult travellers. Cochrane Database Syst Rev 2000;10. 1002/14651858. CD000138CD000138.
4. Croft AM, Garner P: WITHDRAWN: Mefloquine for preventing malaria in non-immune adult travellers. Cochrane Database Syst Rev 2008;10. 1002/14651858. CD000138. pub2CD000138.
5. Gonzalez R, Hellgren U, Greenwood B, Menendez C: Mefloquine safety and tolerability in pregnancy: A systematic literature review. Malar J 2014;13:75.
6. Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Bansod S, Rhein HG: Use of mefloquine in children - A review of dosage, pharmacokinetics and tolerability data. Malar J 2011;10:292.
7. Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Rhein HG: The position of mefloquine as a 21st century malaria chemoprophylaxis. Malar J 2010;9:357.
8. Wongsrichanalai C, Prajakwong S, Meshnick SR, Shanks GD, Thimasarn K: Mefloquine-its 20 years in the Thai Malaria Control Program. Southeast Asian J Trop Med Public Health 2004;35:300-308.
9. Xiao SH: Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies. Parasitol Res 2013;112:3723-3740.
10. Milatovic D, Jenkins JW, Hood JE, Yu Y, Rongzhu L, Aschner M: Mefloquine neurotoxicity is mediated by non-receptor tyrosine kinase. Neurotoxicology 2011;32:578-585.
11. Naing C, Aung K, Ahmed SI, Mak JW: Signal detection to identify serious adverse events (neuropsychiatric events) in travelers taking mefloquine for chemoprophylaxis of malaria. Drug Healthc Patient Saf 2012;4:87-92.
12. Toovey S: Mefloquine neurotoxicity: A literature review. Travel Med Infect Dis 2009;7:2-6.
13. Young BE, Yeo TR, Lim HT, Vong KY, Tan K, Lye DC, Lee CC: Progressive Multifocal Leukoencephalopathy with Immune Reconstitution Inflammatory Syndrome (PML-IRIS): Two case reports of successful treatment with mefloquine and a review of the literature. Ann Acad Med Singapore 2012;41:620-624.
14. Yu D, Ding D, Jiang H, Stolzberg D, Salvi R: Mefloquine damage vestibular hair cells in organotypic cultures. Neurotox Res 2011;20:51-58.
15. Smith HR, Croft AM, Black MM: Dermatological adverse effects with the antimalarial drug mefloquine: A review of 74 published case reports. Clin Exp Dermatol 1999;24:249-254.
16. Nevin RL: Mefloquine gap junction blockade and risk of pregnancy loss. Biol Reprod 2012;87:65.
17. Das S, Lin D, Jena S, Shi A, Battina S, Hua DH, Allbaugh R, Takemoto DJ: Protection of retinal cells from ischemia by a novel gap junction inhibitor. Biochem Biophys Res Commun 2008;373:504-508.
18. Ding D, Qi W, Yu D, Jiang H, Han C, Kim MJ, Katsuno K, Hsieh YH, Miyakawa T, Salvi R, Tanokura M, Someya S: Addition of exogenous NAD+ prevents mefloquine-induced neuroaxonal and hair cell degeneration through reduction of caspase-3-mediated apoptosis in cochlear organotypic cultures. PLoS One 2013;8:e79817.
19. Geng Y, Kohli L, Klocke BJ, Roth KA: Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent. Neuro Oncol 2010;12:473-481.
20. Kim JH, Choi AR, Kim YK, Yoon S: Co-treatment with the anti-malarial drugs mefloquine and primaquine highly sensitizes drug-resistant cancer cells by increasing P-gp inhibition. Biochem Biophys Res Commun 2013;441:655-660.
21. Yadav N, Dwivedi A, Mujtaba SF, Verma A, Chaturvedi R, Ray RS, Singh G: Photosensitized mefloquine induces ROS-mediated DNA damage and apoptosis in keratinocytes under ambient UVB and sunlight exposure. Cell Biol Toxicol 2014;30:253-268.
22. Pankova-Kholmyansky I, Dagan A, Gold D, Zaslavsky Z, Skutelsky E, Gatt S, Flescher E: Ceramide mediates growth inhibition of the Plasmodium falciparum parasite. Cell Mol Life Sci 2003;60:577-587.
23. Foller M, Bobbala D, Koka S, Huber SM, Gulbins E, Lang F: Suicide for survival-death of infected erythrocytes as a host mechanism to survive malaria. Cell Physiol Biochem 2009;24:133-140.
24. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM: Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-C1560.
25. Lang E, Qadri SM, Lang F: Killing me softly-suicidal erythrocyte death. Int J Biochem Cell Biol 2012;44:1236-1243.
26. Abed M, Towhid ST, Mia S, Pakladok T, Alesutan I, Borst O, Gawaz M, Gulbins E, Lang F: Sphingomyelinase-induced adhesion of eryptotic erythrocytes to endothelial cells. Am J Physiol Cell Physiol 2012;303:C991-999.
27. Lau IP, Chen H, Wang J, Ong HC, Leung KC, Ho HP, Kong SK: In vitro effect of CTAB-and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes. Nanotoxicology 2012;6:847-856.
28. Maellaro E, Leoncini S, Moretti D, Del Bello B, Tanganelli I, De Felice C, Ciccoli L: Erythrocyte caspase-3 activation and oxidative imbalance in erythrocytes and in plasma of type 2 diabetic patients. Acta Diabetol 2013;50:489-495.
29. Jilani K, Qadri SM, Lang F: Geldanamycin-induced phosphatidylserine translocation in the erythrocyte membrane. Cell Physiol Biochem 2013;32:1600-1609.
30. Polak-Jonkisz D, Purzyc L: Ca Influx versus Efflux during Eryptosis in Uremic Erythrocytes. Blood Purif 2012;34:209-210.
31. Qian EW, Ge DT, Kong SK: Salidroside protects human erythrocytes against hydrogen peroxide-induced apoptosis. J Nat Prod 2012;75:531-537.
32. Vota DM, Maltaneri RE, Wenker SD, Nesse AB, Vittori DC: Differential erythropoietin action upon cells induced to eryptosis by different agents. Cell Biochem Biophys 2013;65:145-157.
33. Weiss E, Cytlak UM, Rees DC, Osei A, Gibson JS: Deoxygenation-induced and Ca(2+) dependent phosphatidylserine externalisation in red blood cells from normal individuals and sickle cell patients. Cell Calcium 2012;51:51-56.
34. Zbidah M, Lupescu A, Jilani K, Lang F: Stimulation of suicidal erythrocyte death by fumagillin. Basic Clin Pharmacol Toxicol 2013;112:346-351.
35. Abed M, Herrmann T, Alzoubi K, Pakladok T, Lang F: Tannic Acid induced suicidal erythrocyte death. Cell Physiol Biochem 2013;32:1106-1116.
36. Ahmed MS, Langer H, Abed M, Voelkl J, Lang F: The uremic toxin acrolein promotes suicidal erythrocyte death. Kidney Blood Press Res 2013;37:158-167.
37. Ghashghaeinia M, Cluitmans JC, Toulany M, Saki M, Koberle M, Lang E, Dreischer P, Biedermann T, Duszenko M, Lang F, Bosman GJ, Wieder T: Age Sensitivity of NFkappaB Abundance and Programmed Cell Death in Erythrocytes Induced by NFkappaB Inhibitors. Cell Physiol Biochem 2013;32:801-813.
38. Alzoubi K, Honisch S, Abed M, Lang F: Triggering of Suicidal Erythrocyte Death by Penta-O-galloyl-beta-d-glucose. Toxins (Basel) 2014;6:54-65.
39. Lupescu A, Bissinger R, Jilani K, Lang F: Triggering of suicidal erythrocyte death by celecoxib. Toxins (Basel) 2013;5:1543-1554.
40. Lupescu A, Jilani K, Zbidah M, Lang F: Patulin-induced suicidal erythrocyte death. Cell Physiol Biochem 2013;32:291-299.
41. Abed M, Zoubi KA, Theurer M, Lang F: Effect of dermaseptin on erythrocytes. Basic Clin Pharmacol Toxicol 2013;113:347-352.
42. Arnold M, Lang E, Modicano P, Bissinger R, Faggio C, Abed M, Lang F: Effect of nitazoxanide on erythrocytes. Basic Clin Pharmacol Toxicol 2014;114:421-426.
43. Oswald G, Alzoubi K, Abed M, Lang F: Stimulation of suicidal erythrocyte death by ribavirin. Basic Clin Pharmacol Toxicol 2014;114:311-317.
44. Bissinger R, Malik A, Jilani K, Lang F: Triggering of Erythrocyte Cell Membrane Scrambling by Salinomycin. Basic Clin Pharmacol Toxicol 2014;10. 1111/bcpt. 12250
45. Jacobi J, Lang E, Bissinger R, Frauenfeld L, Modicano P, Faggio C, Abed M, Lang F: Stimulation of erythrocyte cell membrane scrambling by mitotane. Cell Physiol Biochem 2014;33:1516-1526.
46. Lupescu A, Bissinger R, Herrmann T, Oswald G, Jilani K, Lang F: Induction of suicidal erythrocyte death by novobiocin. Cell Physiol Biochem 2014;33:670-680.
47. Lupescu A, Bissinger R, Warsi J, Jilani K, Lang F: Stimulation of erythrocyte cell membrane scrambling by gedunin. Cell Physiol Biochem 2014;33:1838-1848.
48. Abed M, Feger M, Alzoubi K, Pakladok T, Frauenfeld L, Geiger C, Towhid ST, Lang F: Sensitization of erythrocytes to suicidal erythrocyte death following water deprivation. Kidney Blood Press Res 2013;37:567-578.
49. Alzoubi K, Calabro S, Bissinger R, Abed M, Faggio C, Lang F: Stimulation of suicidal erythrocyte death by artesunate. Cell Physiol Biochem 2014;34:2232-2244.
50. Arnold M, Bissinger R, Lang F: Mitoxantrone-induced suicidal erythrocyte death. Cell Physiol Biochem 2014;34:1756-1767.
51. Bissinger R, Fischer S, Jilani K, Lang F: Stimulation of erythrocyte death by phloretin. Cell Physiol Biochem 2014;34:2256-2265.
52. Bissinger R, Lupescu A, Zelenak C, Jilani K, Lang F: Stimulation of eryptosis by cryptotanshinone. Cell Physiol Biochem 2014;34:432-442.
53. Bissinger R, Modicano P, Frauenfeld L, Lang E, Jacobi J, Faggio C, Lang F: Estramustine-induced suicidal erythrocyte death. Cell Physiol Biochem 2013;32:1426-1436.
54. Malik A, Bissinger R, Calabro S, Faggio C, Jilani K, Lang F: Aristolochic acid induced suicidal erythrocyte death. Kidney Blood Press Res 2014;39:408-419.
55. Tesoriere L, Attanzio A, Allegra M, Cilla A, Gentile C, Livrea MA: Oxysterol mixture in hypercholesterolemia-relevant proportion causes oxidative stress-dependent eryptosis. Cell Physiol Biochem 2014;34:1075-1089.
56. Voelkl J, Alzoubi K, Mamar AK, Ahmed MS, Abed M, Lang F: Stimulation of suicidal erythrocyte death by increased extracellular phosphate concentrations. Kidney Blood Press Res 2013;38:42-51.
57. Zhang R, Xiang Y, Ran Q, Deng X, Xiao Y, Xiang L, Li Z: Involvement of calcium, reactive oxygen species, and ATP in hexavalent chromium-induced damage in red blood cells. Cell Physiol Biochem 2014;34:1780-1791.
58. Borst O, Abed M, Alesutan I, Towhid ST, Qadri SM, Foller M, Gawaz M, Lang F: Dynamic adhesion of eryptotic erythrocytes to endothelial cells via CXCL16/SR-PSOX. Am J Physiol Cell Physiol 2012;302:C644-C651.
59. Andrews DA, Low PS: Role of red blood cells in thrombosis. Curr Opin Hematol 1999;6:76-82.
60. Chung SM, Bae ON, Lim KM, Noh JY, Lee MY, Jung YS, Chung JH: Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler Thromb Vasc Biol 2007;27:414-421.
61. Zwaal RF, Comfurius P, Bevers EM: Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 2005;62:971-988.
62. Closse C, Dachary-Prigent J, Boisseau MR: Phosphatidylserine-related adhesion of human erythrocytes to vascular endothelium. Br J Haematol 1999;107:300-302.
63. Gallagher PG, Chang SH, Rettig MP, Neely JE, Hillery CA, Smith BD, Low PS: Altered erythrocyte endothelial adherence and membrane phospholipid asymmetry in hereditary hydrocytosis. Blood 2003;101:4625-4627.
64. Pandolfi A, Di Pietro N, Sirolli V, Giardinelli A, Di Silvestre S, Amoroso L, Di Tomo P, Capani F, Consoli A, Bonomini M: Mechanisms of uremic erythrocyte-induced adhesion of human monocytes to cultured endothelial cells. J Cell Physiol 2007;213:699-709.
65. Wood BL, Gibson DF, Tait JF: Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996;88:1873-1880.
66. Boudreau EF, Fleckenstein L, Pang LW, Childs GE, Schroeder AC, Ratnaratorn B, Phintuyothin P: Mefloquine kinetics in cured and recrudescent patients with acute falciparum malaria and in healthy volunteers. Clin Pharmacol Ther 1990;48:399-409.
67. Totino PR, Daniel-Ribeiro CT, Ferreira-da-Cruz Mde F: Pro-apoptotic effects of antimalarial drugs do not affect mature human erythrocytes. Acta Trop 2009;112:236-238.
68. Harrison HE, Bunting H, Ordway NK, Albrink WS: The Pathogenesis of the Renal Injury Produced in the Dog by Hemoglobin or Methemoglobin. J Exp Med 1947;86:339-356.
69. Kirk K: Membrane transport in the malaria-infected erythrocyte. Physiol Rev 2001;81:495-537.
70. Ayi K, Giribaldi G, Skorokhod A, Schwarzer E, Prendergast PT, Arese P: 16alpha-bromoepiandrosterone, an antimalarial analogue of the hormone dehydroepiandrosterone, enhances phagocytosis of ring stage parasitized erythrocytes: A novel mechanism for antimalarial activity. Antimicrob Agents Chemother 2002;46:3180-3184.
71. Ayi K, Turrini F, Piga A, Arese P: Enhanced phagocytosis of ring-parasitized mutant erythrocytes: A common mechanism that may explain protection against falciparum malaria in sickle trait and beta-thalassemia trait. Blood 2004;104:3364-3371.
72. Cappadoro M, Giribaldi G, O'Brien E, Turrini F, Mannu F, Ulliers D, Simula G, Luzzatto L, Arese P: Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood 1998;92:2527-2534.
73. Koka S, Huber SM, Boini KM, Lang C, Foller M, Lang F: Lead decreases parasitemia and enhances survival of Plasmodium berghei-infected mice. Biochem Biophys Res Commun 2007;363:484-489.
74. Koka S, Lang C, Niemoeller OM, Boini KM, Nicolay JP, Huber SM, Lang F: Influence of NO synthase inhibitor L-NAME on parasitemia and survival of Plasmodium berghei infected mice. Cell Physiol Biochem 2008;21:481-488.